Gut-Muscle Axis: Roseburia inulinivorans as a Novel Mediator of Skeletal Muscle Strength and Fiber-Type Composition

Highlights

• Roseburia inulinivorans relative abundance is positively correlated with handgrip, leg press, and bench press strength in humans.
• In vivo supplementation of R. inulinivorans in mice demonstrated a causal increase in forelimb grip strength, a benefit not observed with other Roseburia species.
• The mechanism involves a reduction in systemic amino acids and the activation of purine and pentose phosphate pathways within the muscle tissue.
• Supplementation promotes a shift toward Type II (fast-twitch) muscle fibers and increases overall fiber cross-sectional area.

Background

Sarcopenia and age-related muscle wasting represent a major public health challenge, contributing to frailty, loss of independence, and increased mortality in the elderly. While exercise and protein intake remain the cornerstones of management, there is an urgent need for novel therapeutic targets. Recent research into the ‘gut-muscle axis’ has suggested that the intestinal microbiome plays a pivotal role in regulating skeletal muscle mass and function through systemic metabolic signaling.

Despite the broad association between gut health and physical performance, identifying specific microbial species that exert measurable effects on muscle strength has remained elusive. Prior studies often grouped bacteria at the genus or family level, potentially masking species-specific effects. The emergence of metagenomic and metabolomic integration now allows for the identification of specific candidates like Roseburia inulinivorans as potent modulators of muscle health.

Key Content

Human Metagenomic Correlations

A landmark metagenomic analysis (Martinez-Tellez et al., 2026; NCT02365129) investigated the association between gut microbiota and muscle strength in human cohorts. The results demonstrated that the relative abundance of Roseburia inulinivorans—a butyrate-producing anaerobic bacterium—correlated significantly with multiple strength metrics. Specifically, higher levels of R. inulinivorans were associated with superior handgrip strength, leg press, and bench press performance. Notably, this association was species-specific; other members of the Roseburia genus, such as R. hominis or R. intestinalis, did not exhibit similar correlations with strength measures.

Causality and Animal Models

To establish a causal link, researchers supplemented antibiotic-treated mice with R. inulinivorans. The oral administration of this specific strain led to a significant increase in forelimb grip strength compared to controls. This effect was absent in mice supplemented with other Roseburia species, confirming the unique functional niche of R. inulinivorans. These findings suggest that the bacterium provides specific metabolites or signaling cues that are not redundant within the genus.

Mechanistic Insights: Metabolic Reprogramming

Metabolomic profiling of caecal content and plasma in the R. inulinivorans-treated models revealed a distinct reduction in amino acid concentrations. This depletion suggests an increased uptake or utilization of these substrates for anabolic processes. Furthermore, skeletal muscle analysis showed a marked activation of the pentose phosphate pathway (PPP) and the purine metabolic pathway. The PPP is essential for providing ribose-5-phosphate for nucleotide synthesis and maintaining redox balance, both of which are critical for muscle repair and hypertrophy.

Phenotypic Changes in Muscle Morphology

The metabolic shifts induced by R. inulinivorans translated into observable physiological changes. Muscles from treated subjects showed:

• Increased Fiber Size: A measurable increase in the cross-sectional area of muscle fibers.
• Fiber Type Transition: A shift from Type I (slow-twitch, oxidative) to Type II (fast-twitch, glycolytic) fibers.

Type II fibers are primarily responsible for explosive power and peak strength, which aligns with the observed improvements in grip and press metrics.

Expert Commentary

The discovery of R. inulinivorans as a specific strength-enhancing microbe is a significant leap forward in the gut-muscle axis research. Clinically, the most striking finding is the decline of this bacterium in older adults. This decline suggests that the loss of R. inulinivorans may be a contributing factor to, rather than just a consequence of, the sarcopenic phenotype. From a clinician’s perspective, this provides a clear rationale for investigating R. inulinivorans as a next-generation probiotic (NGP).

However, several limitations must be addressed. While the animal data is robust, the metabolic mechanisms—particularly how a reduction in systemic amino acids correlates with increased muscle anabolism—require further clarification. It is possible that R. inulinivorans enhances the efficiency of amino acid transport into the myocyte. Furthermore, the transition toward Type II fibers, while beneficial for strength, must be balanced against oxidative capacity and endurance, especially in elderly patients with comorbid metabolic diseases.

Conclusion

Roseburia inulinivorans has emerged as a key species-specific modulator of muscle strength. By redirecting metabolic pathways toward purine synthesis and Type II fiber hypertrophy, it offers a promising target for nutraceutical and probiotic interventions. Future clinical trials should focus on whether targeted restoration of this species can reverse strength loss in elderly populations or improve recovery in patients with muscle-wasting conditions such as cachexia.

References

• Martinez-Tellez B, Schönke M, Kovynev A, et al. Roseburia inulinivorans increases muscle strength. Gut. 2026-03-10. PMID: 41806991.
• Sarcopenia and Gut Microbiota: Emerging Evidence. Clinical Interventions in Aging (General Context).
• Gut-Muscle Axis: Metabolic Signaling Pathways. Nature Metabolism (General Context).